1 / 15

Early Detection of Hypertrophic Cardiomyopathy

Early Detection of Hypertrophic Cardiomyopathy. Katie Wilson, Heather Dixon Lindsey, Aneta Petri, Kaycee Stone. Objectives. Define causes of hypertrophic cardiomyopathy Identify signs & symptoms Discuss differential diagnosis compared to typical athlete ’ s heart

axelle
Download Presentation

Early Detection of Hypertrophic Cardiomyopathy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Early Detection of Hypertrophic Cardiomyopathy Katie Wilson, Heather Dixon Lindsey, Aneta Petri, Kaycee Stone

  2. Objectives • Define causes of hypertrophic cardiomyopathy • Identify signs & symptoms • Discuss differential diagnosis compared to typical athlete’s heart • Discuss physicals, deconditioning, EKG, and advanced cardiac imaging

  3. What is Hypertrophic Cardiomyopathy (HCM)? • Autosomal dominant (Chun et al., 2010) • Most common genetic heart disease • 11 genetic mutations (Maron, 2009) • Males>Females (Corrado et al., 2005) • Left ventricular hypertrophy (Chun et al., 2010) • 1/3 of sudden deaths in U.S. (Corrado et al., 2005)

  4. Normal Heart vs. HCM From: Mayo Clinic, http://www.mayoclinic.com/health/medical/IM00586

  5. Signs and Symptoms • Chest pain/discomfort • Syncope (Chun et al., 2010) • Irregular heartbeat/palpitations • Shortness of breath/dyspnea • Fatigue out of proportion to exertion • Positive family history (Corrada et al., 2005)

  6. Differential Diagnosis of HCM in Athletes: Challenges Typical Athletic Heart Athletic Heart with HCM LV thickness >15 mm (Chun et al., 2010) Positive genetic testing/ family history (Maron, 2009) Abnormal LV filling L atrial enlargement Bizarre ECG changes • Adaptations to training (Neary et. al, 2011) • LV remodelling <13 mm (Maron, 2009) • L atrial enlargement • Bizarre ECG changes

  7. Our Investigation P: Athletes with family history of HCM or experienced cardiac S/S I: Cardiac Imaging C: Traditional medical sports physicals O: Early detection of HCM

  8. Traditional Sports Physicals in the U.S. • Personal history • Family history • Physical examination • Heart sounds and rhythm • Musculoskeletal features (Marfan syndrome) • Blood pressure and femoral pulses (Corrado et al., 2006)

  9. 12-lead EKG • Mandatory part of European sports physicals (Corrado et al., 2005) • 26-year Italian study on pre-screening athletes (Corrado et al., 2006) • 89% decrease in incidence of sudden CV death over period of study From: Corrado et al., 2005

  10. T-wave Inversion From: Neary et al., 2011

  11. Deconditioning Period • Forced detraining 8-12 weeks (Printz, 2012) • Non-invasive diagnostic method • Athletic heart: physiological changes after • HCM heart: no physiological changes after

  12. Advanced Cardiac Imaging • Exercise echocardiograph stress testing (Printz, 2012) • Cardiac CT scan • Cardiac MRI (Neary et al.,2011) • Ballistocardiography • Doppler ultrasound (Maron, 2009)

  13. Conclusions • Adding 12-lead EKG to sports physicals can detect cardiac abnormalities • Study: Saved 360 kids before age 21(Anderson et al., 2013) • Cost limitations of implementing in U.S. • Advanced cardiac imaging is still needed for diagnosis

  14. For More Information • http://www.youtube.com/watch?v=MhxkyUV6NSA&list=PL39C030C007545A9 • Cleveland Clinic: http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/hypertrophic-cardiomyopathy/

  15. References • Anderson BR, McElligott S, Polsky D, Vetter VL. Electrocardiographic screening for hypertrophic cardiomyopathy and long QT syndrome: the drivers of cost-effectiveness for the prevention of sudden cardiac death. Pediatr Cardiol. Sept 5 2013[Epub ahead of print]. • Chun EJ, Choi SI, Jin KN, Kwag HJ, et al. Hypertrophic cardiomyopathy: assessment with MR imaging and multi-detecter CT. RadioGraphics. 2010;30(5):1309-1328. • Corrado D, Pelliccia A, Bjornstad HH, et al. Cardiovascular pre-participation screening of young competitive athletes for a prevention of sudden death: proposal for a common European protocol. Eur Heart J. Feb 2005;26(5):516-24. • Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA. 2006;296(13):1593-1601. • Maron BJ. Distinguishing hypertrophic cardiomyopathy from athlete’s heart physiological remondeling: clinical significance, diagnostic strategies and implications for preparticipation screening. Br J Sports Med. 2009;43:649-656. • Neary JP, MacQuarrie DS, Jamnik V, Gledhill N, Gledhill S, Busse EFG. Assessment of mechanical cardiac function in elite athletes. Open Sports Med J. 2011;5:26-37. • Printz BF. Noninvasive imaging modalities and sudden cardiac arrest in the young: can they help distinguish subjects with a potentially life-threatening abnormality from the normals? Pediatr Cardiol. 2012;33(3):439-51.

More Related